SCHEMBL1745830

SCHEMBL1745830

CC[C@H](O)C(=O)N1CCCC1c1ncc(-c2ccc(-c3ccc(-c4cnc([C@@H]5CCCN5C(=O)[C@@H](c5ccccc5)N(C)C(=O)O)[nH]4)cc3)cc2)[nH]1

nearest known ligand 0.63

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 2/20 0.63
PRCP P42785 10/20 0.51
CYP3A4 P08684 3/20 0.51
CYP2C9 P11712 3/20 0.51
NR1I2 O75469 1/20 0.51
ABCB11 O95342 1/20 0.51
OPRK1 P41145 1/20 0.51
OPRM1 P35372 2/20 0.48
OPRD1 P41143 2/20 0.48
CYP1A2 P05177 2/20 0.48
CYP2D6 P10635 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1745826 1.00 KCNH2 (0.63) KCNH2PRCPCYP3A4CYP2C9NR1I2
SCHEMBL15673811 0.93 KCNH2 (0.65) KCNH2PRCPCYP3A4CYP2C9NR1I2
SCHEMBL2582507 0.93 KCNH2 (0.65) KCNH2PRCPCYP3A4CYP2C9NR1I2
SCHEMBL1746952 0.91 KCNH2 (0.66) KCNH2PRCPCYP3A4CYP2C9NR1I2
SCHEMBL2576513 0.91 KCNH2 (0.75) KCNH2PRCPCYP3A4CYP2C9NR1I2
SCHEMBL1746956 0.91 KCNH2 (0.66) KCNH2PRCPCYP3A4CYP2C9NR1I2
SCHEMBL1746967 0.91 KCNH2 (0.63) KCNH2PRCPCYP3A4CYP2C9NR1I2
SCHEMBL1746965 0.91 KCNH2 (0.63) KCNH2PRCPCYP3A4CYP2C9NR1I2
SCHEMBL2585114 0.91 KCNH2 (0.61) KCNH2PRCPCYP3A4CYP2C9NR1I2
SCHEMBL1745283 0.91 KCNH2 (0.63) KCNH2PRCPCYP3A4CYP2C9NR1I2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2385048-A1 Hepatitis C virus inhibitors Bristol-Myers Squibb Company (US) 2011-11-09 EP disclosed
US-20110252687-A1 Canting Vertical Fore Grip with Bipod GRIP POD SYSTEMS, LLC 2011-10-20 US disclosed